nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.00945	0.768	CbGdCrCtD
Moxifloxacin—Sparfloxacin—ABCC2—epilepsy syndrome	0.00195	0.25	CrCbGaD
Moxifloxacin—Lomefloxacin—ABCC2—epilepsy syndrome	0.00161	0.206	CrCbGaD
Moxifloxacin—Ofloxacin—ABCC2—epilepsy syndrome	0.00137	0.176	CrCbGaD
Moxifloxacin—TOP2A—Bortezomib—Lacosamide—epilepsy syndrome	0.00125	0.101	CbGdCrCtD
Moxifloxacin—Gatifloxacin—ALB—epilepsy syndrome	0.00115	0.148	CrCbGaD
Moxifloxacin—TOP2A—Niclosamide—Clonazepam—epilepsy syndrome	0.000864	0.0703	CbGdCrCtD
Moxifloxacin—TOP2A—Chlorpromazine—Clobazam—epilepsy syndrome	0.000741	0.0603	CbGdCrCtD
Moxifloxacin—Sparfloxacin—ABCB1—epilepsy syndrome	0.000717	0.0921	CrCbGaD
Moxifloxacin—Levofloxacin—ABCB1—epilepsy syndrome	0.000505	0.0648	CrCbGaD
Moxifloxacin—Ciprofloxacin—ABCB1—epilepsy syndrome	0.000488	0.0626	CrCbGaD
Moxifloxacin—Anxiety—Pregabalin—epilepsy syndrome	9.94e-05	0.000101	CcSEcCtD
Moxifloxacin—Diarrhoea—Clonazepam—epilepsy syndrome	9.93e-05	0.000101	CcSEcCtD
Moxifloxacin—Anaemia—Gabapentin—epilepsy syndrome	9.92e-05	0.000101	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.9e-05	0.000101	CcSEcCtD
Moxifloxacin—Hypotension—Valproic Acid—epilepsy syndrome	9.88e-05	0.000101	CcSEcCtD
Moxifloxacin—Asthenia—Carbamazepine—epilepsy syndrome	9.88e-05	0.000101	CcSEcCtD
Moxifloxacin—Agitation—Gabapentin—epilepsy syndrome	9.87e-05	0.000101	CcSEcCtD
Moxifloxacin—Diarrhoea—Phenytoin—epilepsy syndrome	9.87e-05	0.000101	CcSEcCtD
Moxifloxacin—Discomfort—Pregabalin—epilepsy syndrome	9.85e-05	0.000101	CcSEcCtD
Moxifloxacin—Nausea—Fosphenytoin—epilepsy syndrome	9.84e-05	0.0001	CcSEcCtD
Moxifloxacin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.81e-05	0.0001	CcSEcCtD
Moxifloxacin—Erythema multiforme—Topiramate—epilepsy syndrome	9.81e-05	0.0001	CcSEcCtD
Moxifloxacin—Angioedema—Gabapentin—epilepsy syndrome	9.81e-05	0.0001	CcSEcCtD
Moxifloxacin—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.8e-05	0.0001	CcSEcCtD
Moxifloxacin—Vomiting—Felbamate—epilepsy syndrome	9.78e-05	9.99e-05	CcSEcCtD
Moxifloxacin—Dry mouth—Pregabalin—epilepsy syndrome	9.75e-05	9.95e-05	CcSEcCtD
Moxifloxacin—Pruritus—Carbamazepine—epilepsy syndrome	9.74e-05	9.94e-05	CcSEcCtD
Moxifloxacin—Rash—Felbamate—epilepsy syndrome	9.7e-05	9.9e-05	CcSEcCtD
Moxifloxacin—Eye disorder—Topiramate—epilepsy syndrome	9.7e-05	9.9e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Felbamate—epilepsy syndrome	9.69e-05	9.89e-05	CcSEcCtD
Moxifloxacin—Malaise—Gabapentin—epilepsy syndrome	9.68e-05	9.88e-05	CcSEcCtD
Moxifloxacin—Tinnitus—Topiramate—epilepsy syndrome	9.68e-05	9.87e-05	CcSEcCtD
Moxifloxacin—Vertigo—Gabapentin—epilepsy syndrome	9.65e-05	9.85e-05	CcSEcCtD
Moxifloxacin—Headache—Felbamate—epilepsy syndrome	9.64e-05	9.84e-05	CcSEcCtD
Moxifloxacin—Confusional state—Pregabalin—epilepsy syndrome	9.64e-05	9.83e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.63e-05	9.83e-05	CcSEcCtD
Moxifloxacin—Cardiac disorder—Topiramate—epilepsy syndrome	9.63e-05	9.83e-05	CcSEcCtD
Moxifloxacin—Syncope—Gabapentin—epilepsy syndrome	9.63e-05	9.83e-05	CcSEcCtD
Moxifloxacin—Leukopenia—Gabapentin—epilepsy syndrome	9.61e-05	9.81e-05	CcSEcCtD
Moxifloxacin—Dizziness—Clonazepam—epilepsy syndrome	9.6e-05	9.8e-05	CcSEcCtD
Moxifloxacin—Nausea—Vigabatrin—epilepsy syndrome	9.59e-05	9.79e-05	CcSEcCtD
Moxifloxacin—Vomiting—Zonisamide—epilepsy syndrome	9.58e-05	9.77e-05	CcSEcCtD
Moxifloxacin—Insomnia—Valproic Acid—epilepsy syndrome	9.56e-05	9.76e-05	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Pregabalin—epilepsy syndrome	9.56e-05	9.75e-05	CcSEcCtD
Moxifloxacin—Oedema—Pregabalin—epilepsy syndrome	9.56e-05	9.75e-05	CcSEcCtD
Moxifloxacin—Asthenia—Lamotrigine—epilepsy syndrome	9.55e-05	9.74e-05	CcSEcCtD
Moxifloxacin—Dizziness—Phenytoin—epilepsy syndrome	9.54e-05	9.73e-05	CcSEcCtD
Moxifloxacin—Rash—Zonisamide—epilepsy syndrome	9.5e-05	9.69e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Valproic Acid—epilepsy syndrome	9.49e-05	9.69e-05	CcSEcCtD
Moxifloxacin—Palpitations—Gabapentin—epilepsy syndrome	9.49e-05	9.68e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Zonisamide—epilepsy syndrome	9.49e-05	9.68e-05	CcSEcCtD
Moxifloxacin—Dizziness—Oxcarbazepine—epilepsy syndrome	9.49e-05	9.68e-05	CcSEcCtD
Moxifloxacin—Nausea—Diazepam—epilepsy syndrome	9.44e-05	9.64e-05	CcSEcCtD
Moxifloxacin—Loss of consciousness—Gabapentin—epilepsy syndrome	9.44e-05	9.63e-05	CcSEcCtD
Moxifloxacin—Headache—Zonisamide—epilepsy syndrome	9.44e-05	9.63e-05	CcSEcCtD
Moxifloxacin—Dyspnoea—Valproic Acid—epilepsy syndrome	9.42e-05	9.62e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Carbamazepine—epilepsy syndrome	9.42e-05	9.61e-05	CcSEcCtD
Moxifloxacin—Angiopathy—Topiramate—epilepsy syndrome	9.42e-05	9.61e-05	CcSEcCtD
Moxifloxacin—Pruritus—Lamotrigine—epilepsy syndrome	9.41e-05	9.61e-05	CcSEcCtD
Moxifloxacin—Shock—Pregabalin—epilepsy syndrome	9.4e-05	9.6e-05	CcSEcCtD
Moxifloxacin—Somnolence—Valproic Acid—epilepsy syndrome	9.4e-05	9.59e-05	CcSEcCtD
Moxifloxacin—Immune system disorder—Topiramate—epilepsy syndrome	9.37e-05	9.57e-05	CcSEcCtD
Moxifloxacin—Nervous system disorder—Pregabalin—epilepsy syndrome	9.37e-05	9.56e-05	CcSEcCtD
Moxifloxacin—Cough—Gabapentin—epilepsy syndrome	9.37e-05	9.56e-05	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Pregabalin—epilepsy syndrome	9.36e-05	9.55e-05	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Topiramate—epilepsy syndrome	9.35e-05	9.54e-05	CcSEcCtD
Moxifloxacin—Tachycardia—Pregabalin—epilepsy syndrome	9.33e-05	9.52e-05	CcSEcCtD
Moxifloxacin—Chills—Topiramate—epilepsy syndrome	9.31e-05	9.5e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Valproic Acid—epilepsy syndrome	9.31e-05	9.5e-05	CcSEcCtD
Moxifloxacin—Convulsion—Gabapentin—epilepsy syndrome	9.3e-05	9.49e-05	CcSEcCtD
Moxifloxacin—Skin disorder—Pregabalin—epilepsy syndrome	9.28e-05	9.47e-05	CcSEcCtD
Moxifloxacin—Hypertension—Gabapentin—epilepsy syndrome	9.27e-05	9.46e-05	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.24e-05	9.43e-05	CcSEcCtD
Moxifloxacin—Vomiting—Clonazepam—epilepsy syndrome	9.23e-05	9.42e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Valproic Acid—epilepsy syndrome	9.19e-05	9.38e-05	CcSEcCtD
Moxifloxacin—Vomiting—Phenytoin—epilepsy syndrome	9.17e-05	9.36e-05	CcSEcCtD
Moxifloxacin—Rash—Clonazepam—epilepsy syndrome	9.15e-05	9.34e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Clonazepam—epilepsy syndrome	9.15e-05	9.33e-05	CcSEcCtD
Moxifloxacin—Arthralgia—Gabapentin—epilepsy syndrome	9.14e-05	9.33e-05	CcSEcCtD
Moxifloxacin—Chest pain—Gabapentin—epilepsy syndrome	9.14e-05	9.33e-05	CcSEcCtD
Moxifloxacin—Myalgia—Gabapentin—epilepsy syndrome	9.14e-05	9.33e-05	CcSEcCtD
Moxifloxacin—Nausea—Felbamate—epilepsy syndrome	9.14e-05	9.33e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.13e-05	9.31e-05	CcSEcCtD
Moxifloxacin—Vomiting—Oxcarbazepine—epilepsy syndrome	9.12e-05	9.31e-05	CcSEcCtD
Moxifloxacin—Fatigue—Valproic Acid—epilepsy syndrome	9.11e-05	9.3e-05	CcSEcCtD
Moxifloxacin—Anxiety—Gabapentin—epilepsy syndrome	9.11e-05	9.3e-05	CcSEcCtD
Moxifloxacin—Anorexia—Pregabalin—epilepsy syndrome	9.11e-05	9.3e-05	CcSEcCtD
Moxifloxacin—Dizziness—Carbamazepine—epilepsy syndrome	9.1e-05	9.29e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Lamotrigine—epilepsy syndrome	9.1e-05	9.29e-05	CcSEcCtD
Moxifloxacin—Headache—Clonazepam—epilepsy syndrome	9.1e-05	9.28e-05	CcSEcCtD
Moxifloxacin—Rash—Phenytoin—epilepsy syndrome	9.09e-05	9.28e-05	CcSEcCtD
Moxifloxacin—Mental disorder—Topiramate—epilepsy syndrome	9.09e-05	9.28e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Phenytoin—epilepsy syndrome	9.08e-05	9.27e-05	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	9.08e-05	9.27e-05	CcSEcCtD
Moxifloxacin—Rash—Oxcarbazepine—epilepsy syndrome	9.04e-05	9.23e-05	CcSEcCtD
Moxifloxacin—Pain—Valproic Acid—epilepsy syndrome	9.04e-05	9.23e-05	CcSEcCtD
Moxifloxacin—Constipation—Valproic Acid—epilepsy syndrome	9.04e-05	9.23e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.04e-05	9.22e-05	CcSEcCtD
Moxifloxacin—Headache—Phenytoin—epilepsy syndrome	9.03e-05	9.22e-05	CcSEcCtD
Moxifloxacin—Malnutrition—Topiramate—epilepsy syndrome	9.03e-05	9.22e-05	CcSEcCtD
Moxifloxacin—Erythema—Topiramate—epilepsy syndrome	9.03e-05	9.22e-05	CcSEcCtD
Moxifloxacin—Discomfort—Gabapentin—epilepsy syndrome	9.03e-05	9.22e-05	CcSEcCtD
Moxifloxacin—Headache—Oxcarbazepine—epilepsy syndrome	8.99e-05	9.17e-05	CcSEcCtD
Moxifloxacin—Nausea—Zonisamide—epilepsy syndrome	8.95e-05	9.13e-05	CcSEcCtD
Moxifloxacin—Dry mouth—Gabapentin—epilepsy syndrome	8.94e-05	9.12e-05	CcSEcCtD
Moxifloxacin—Hypotension—Pregabalin—epilepsy syndrome	8.93e-05	9.11e-05	CcSEcCtD
Moxifloxacin—Flatulence—Topiramate—epilepsy syndrome	8.9e-05	9.08e-05	CcSEcCtD
Moxifloxacin—Tension—Topiramate—epilepsy syndrome	8.87e-05	9.05e-05	CcSEcCtD
Moxifloxacin—Dysgeusia—Topiramate—epilepsy syndrome	8.85e-05	9.03e-05	CcSEcCtD
Moxifloxacin—Confusional state—Gabapentin—epilepsy syndrome	8.84e-05	9.02e-05	CcSEcCtD
Moxifloxacin—Dizziness—Lamotrigine—epilepsy syndrome	8.8e-05	8.98e-05	CcSEcCtD
Moxifloxacin—Nervousness—Topiramate—epilepsy syndrome	8.77e-05	8.95e-05	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.76e-05	8.94e-05	CcSEcCtD
Moxifloxacin—Oedema—Gabapentin—epilepsy syndrome	8.76e-05	8.94e-05	CcSEcCtD
Moxifloxacin—Vomiting—Carbamazepine—epilepsy syndrome	8.75e-05	8.93e-05	CcSEcCtD
Moxifloxacin—Back pain—Topiramate—epilepsy syndrome	8.74e-05	8.92e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.71e-05	8.89e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.71e-05	8.89e-05	CcSEcCtD
Moxifloxacin—Muscle spasms—Topiramate—epilepsy syndrome	8.69e-05	8.86e-05	CcSEcCtD
Moxifloxacin—Rash—Carbamazepine—epilepsy syndrome	8.68e-05	8.86e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Carbamazepine—epilepsy syndrome	8.67e-05	8.85e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.64e-05	8.82e-05	CcSEcCtD
Moxifloxacin—Insomnia—Pregabalin—epilepsy syndrome	8.64e-05	8.82e-05	CcSEcCtD
Moxifloxacin—Nausea—Clonazepam—epilepsy syndrome	8.62e-05	8.8e-05	CcSEcCtD
Moxifloxacin—Headache—Carbamazepine—epilepsy syndrome	8.62e-05	8.8e-05	CcSEcCtD
Moxifloxacin—Shock—Gabapentin—epilepsy syndrome	8.62e-05	8.8e-05	CcSEcCtD
Moxifloxacin—Nervous system disorder—Gabapentin—epilepsy syndrome	8.59e-05	8.77e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Pregabalin—epilepsy syndrome	8.58e-05	8.76e-05	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.58e-05	8.76e-05	CcSEcCtD
Moxifloxacin—Nausea—Phenytoin—epilepsy syndrome	8.57e-05	8.74e-05	CcSEcCtD
Moxifloxacin—Tachycardia—Gabapentin—epilepsy syndrome	8.55e-05	8.73e-05	CcSEcCtD
Moxifloxacin—Dyspnoea—Pregabalin—epilepsy syndrome	8.52e-05	8.7e-05	CcSEcCtD
Moxifloxacin—Nausea—Oxcarbazepine—epilepsy syndrome	8.52e-05	8.7e-05	CcSEcCtD
Moxifloxacin—Vision blurred—Topiramate—epilepsy syndrome	8.51e-05	8.69e-05	CcSEcCtD
Moxifloxacin—Skin disorder—Gabapentin—epilepsy syndrome	8.51e-05	8.69e-05	CcSEcCtD
Moxifloxacin—Somnolence—Pregabalin—epilepsy syndrome	8.5e-05	8.67e-05	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.47e-05	8.65e-05	CcSEcCtD
Moxifloxacin—Tremor—Topiramate—epilepsy syndrome	8.46e-05	8.64e-05	CcSEcCtD
Moxifloxacin—Vomiting—Lamotrigine—epilepsy syndrome	8.46e-05	8.63e-05	CcSEcCtD
Moxifloxacin—Urticaria—Valproic Acid—epilepsy syndrome	8.4e-05	8.57e-05	CcSEcCtD
Moxifloxacin—Rash—Lamotrigine—epilepsy syndrome	8.39e-05	8.56e-05	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Topiramate—epilepsy syndrome	8.38e-05	8.55e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Lamotrigine—epilepsy syndrome	8.38e-05	8.55e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Valproic Acid—epilepsy syndrome	8.36e-05	8.53e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Valproic Acid—epilepsy syndrome	8.36e-05	8.53e-05	CcSEcCtD
Moxifloxacin—Anorexia—Gabapentin—epilepsy syndrome	8.35e-05	8.52e-05	CcSEcCtD
Moxifloxacin—Anaemia—Topiramate—epilepsy syndrome	8.35e-05	8.52e-05	CcSEcCtD
Moxifloxacin—Headache—Lamotrigine—epilepsy syndrome	8.33e-05	8.51e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Pregabalin—epilepsy syndrome	8.31e-05	8.48e-05	CcSEcCtD
Moxifloxacin—Agitation—Topiramate—epilepsy syndrome	8.3e-05	8.47e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.25e-05	8.42e-05	CcSEcCtD
Moxifloxacin—Fatigue—Pregabalin—epilepsy syndrome	8.24e-05	8.41e-05	CcSEcCtD
Moxifloxacin—Hypotension—Gabapentin—epilepsy syndrome	8.19e-05	8.36e-05	CcSEcCtD
Moxifloxacin—Nausea—Carbamazepine—epilepsy syndrome	8.18e-05	8.34e-05	CcSEcCtD
Moxifloxacin—Pain—Pregabalin—epilepsy syndrome	8.17e-05	8.34e-05	CcSEcCtD
Moxifloxacin—Constipation—Pregabalin—epilepsy syndrome	8.17e-05	8.34e-05	CcSEcCtD
Moxifloxacin—Malaise—Topiramate—epilepsy syndrome	8.15e-05	8.31e-05	CcSEcCtD
Moxifloxacin—Vertigo—Topiramate—epilepsy syndrome	8.12e-05	8.28e-05	CcSEcCtD
Moxifloxacin—Syncope—Topiramate—epilepsy syndrome	8.1e-05	8.27e-05	CcSEcCtD
Moxifloxacin—Leukopenia—Topiramate—epilepsy syndrome	8.09e-05	8.25e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.98e-05	8.15e-05	CcSEcCtD
Moxifloxacin—Palpitations—Topiramate—epilepsy syndrome	7.98e-05	8.15e-05	CcSEcCtD
Moxifloxacin—Loss of consciousness—Topiramate—epilepsy syndrome	7.94e-05	8.1e-05	CcSEcCtD
Moxifloxacin—Insomnia—Gabapentin—epilepsy syndrome	7.93e-05	8.09e-05	CcSEcCtD
Moxifloxacin—Nausea—Lamotrigine—epilepsy syndrome	7.9e-05	8.06e-05	CcSEcCtD
Moxifloxacin—Cough—Topiramate—epilepsy syndrome	7.88e-05	8.04e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Pregabalin—epilepsy syndrome	7.88e-05	8.04e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Gabapentin—epilepsy syndrome	7.87e-05	8.03e-05	CcSEcCtD
Moxifloxacin—Convulsion—Topiramate—epilepsy syndrome	7.83e-05	7.99e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.82e-05	7.98e-05	CcSEcCtD
Moxifloxacin—Dyspnoea—Gabapentin—epilepsy syndrome	7.81e-05	7.97e-05	CcSEcCtD
Moxifloxacin—Hypertension—Topiramate—epilepsy syndrome	7.8e-05	7.96e-05	CcSEcCtD
Moxifloxacin—Somnolence—Gabapentin—epilepsy syndrome	7.79e-05	7.95e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.79e-05	7.95e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Gabapentin—epilepsy syndrome	7.71e-05	7.87e-05	CcSEcCtD
Moxifloxacin—Myalgia—Topiramate—epilepsy syndrome	7.69e-05	7.85e-05	CcSEcCtD
Moxifloxacin—Arthralgia—Topiramate—epilepsy syndrome	7.69e-05	7.85e-05	CcSEcCtD
Moxifloxacin—Chest pain—Topiramate—epilepsy syndrome	7.69e-05	7.85e-05	CcSEcCtD
Moxifloxacin—Anxiety—Topiramate—epilepsy syndrome	7.66e-05	7.82e-05	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.64e-05	7.79e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Gabapentin—epilepsy syndrome	7.62e-05	7.77e-05	CcSEcCtD
Moxifloxacin—Discomfort—Topiramate—epilepsy syndrome	7.6e-05	7.75e-05	CcSEcCtD
Moxifloxacin—Urticaria—Pregabalin—epilepsy syndrome	7.59e-05	7.75e-05	CcSEcCtD
Moxifloxacin—Asthenia—Valproic Acid—epilepsy syndrome	7.58e-05	7.74e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.57e-05	7.72e-05	CcSEcCtD
Moxifloxacin—Fatigue—Gabapentin—epilepsy syndrome	7.56e-05	7.71e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Pregabalin—epilepsy syndrome	7.56e-05	7.71e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Pregabalin—epilepsy syndrome	7.56e-05	7.71e-05	CcSEcCtD
Moxifloxacin—Dry mouth—Topiramate—epilepsy syndrome	7.52e-05	7.68e-05	CcSEcCtD
Moxifloxacin—Pain—Gabapentin—epilepsy syndrome	7.49e-05	7.65e-05	CcSEcCtD
Moxifloxacin—Constipation—Gabapentin—epilepsy syndrome	7.49e-05	7.65e-05	CcSEcCtD
Moxifloxacin—Pruritus—Valproic Acid—epilepsy syndrome	7.48e-05	7.63e-05	CcSEcCtD
Moxifloxacin—Confusional state—Topiramate—epilepsy syndrome	7.43e-05	7.59e-05	CcSEcCtD
Moxifloxacin—Oedema—Topiramate—epilepsy syndrome	7.37e-05	7.52e-05	CcSEcCtD
Moxifloxacin—Shock—Topiramate—epilepsy syndrome	7.25e-05	7.4e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Valproic Acid—epilepsy syndrome	7.23e-05	7.38e-05	CcSEcCtD
Moxifloxacin—Nervous system disorder—Topiramate—epilepsy syndrome	7.23e-05	7.38e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Gabapentin—epilepsy syndrome	7.22e-05	7.37e-05	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Topiramate—epilepsy syndrome	7.22e-05	7.37e-05	CcSEcCtD
Moxifloxacin—Tachycardia—Topiramate—epilepsy syndrome	7.2e-05	7.34e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.17e-05	7.31e-05	CcSEcCtD
Moxifloxacin—Skin disorder—Topiramate—epilepsy syndrome	7.16e-05	7.31e-05	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Topiramate—epilepsy syndrome	7.13e-05	7.27e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Pregabalin—epilepsy syndrome	7.04e-05	7.19e-05	CcSEcCtD
Moxifloxacin—Anorexia—Topiramate—epilepsy syndrome	7.03e-05	7.17e-05	CcSEcCtD
Moxifloxacin—Dizziness—Valproic Acid—epilepsy syndrome	6.99e-05	7.13e-05	CcSEcCtD
Moxifloxacin—Urticaria—Gabapentin—epilepsy syndrome	6.96e-05	7.1e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Gabapentin—epilepsy syndrome	6.93e-05	7.07e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Gabapentin—epilepsy syndrome	6.93e-05	7.07e-05	CcSEcCtD
Moxifloxacin—Hypotension—Topiramate—epilepsy syndrome	6.89e-05	7.03e-05	CcSEcCtD
Moxifloxacin—Asthenia—Pregabalin—epilepsy syndrome	6.86e-05	7e-05	CcSEcCtD
Moxifloxacin—Pruritus—Pregabalin—epilepsy syndrome	6.76e-05	6.9e-05	CcSEcCtD
Moxifloxacin—Vomiting—Valproic Acid—epilepsy syndrome	6.72e-05	6.86e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.72e-05	6.86e-05	CcSEcCtD
Moxifloxacin—Insomnia—Topiramate—epilepsy syndrome	6.67e-05	6.81e-05	CcSEcCtD
Moxifloxacin—Rash—Valproic Acid—epilepsy syndrome	6.67e-05	6.8e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Valproic Acid—epilepsy syndrome	6.66e-05	6.8e-05	CcSEcCtD
Moxifloxacin—Headache—Valproic Acid—epilepsy syndrome	6.62e-05	6.76e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Topiramate—epilepsy syndrome	6.62e-05	6.76e-05	CcSEcCtD
Moxifloxacin—Dyspnoea—Topiramate—epilepsy syndrome	6.57e-05	6.71e-05	CcSEcCtD
Moxifloxacin—Somnolence—Topiramate—epilepsy syndrome	6.55e-05	6.69e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Pregabalin—epilepsy syndrome	6.54e-05	6.67e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Topiramate—epilepsy syndrome	6.49e-05	6.62e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Gabapentin—epilepsy syndrome	6.46e-05	6.59e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Topiramate—epilepsy syndrome	6.41e-05	6.54e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.37e-05	6.5e-05	CcSEcCtD
Moxifloxacin—Fatigue—Topiramate—epilepsy syndrome	6.36e-05	6.49e-05	CcSEcCtD
Moxifloxacin—Dizziness—Pregabalin—epilepsy syndrome	6.32e-05	6.45e-05	CcSEcCtD
Moxifloxacin—Pain—Topiramate—epilepsy syndrome	6.3e-05	6.43e-05	CcSEcCtD
Moxifloxacin—Constipation—Topiramate—epilepsy syndrome	6.3e-05	6.43e-05	CcSEcCtD
Moxifloxacin—Asthenia—Gabapentin—epilepsy syndrome	6.29e-05	6.42e-05	CcSEcCtD
Moxifloxacin—Nausea—Valproic Acid—epilepsy syndrome	6.28e-05	6.41e-05	CcSEcCtD
Moxifloxacin—Pruritus—Gabapentin—epilepsy syndrome	6.2e-05	6.33e-05	CcSEcCtD
Moxifloxacin—Vomiting—Pregabalin—epilepsy syndrome	6.08e-05	6.2e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Topiramate—epilepsy syndrome	6.08e-05	6.2e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.03e-05	6.15e-05	CcSEcCtD
Moxifloxacin—Rash—Pregabalin—epilepsy syndrome	6.03e-05	6.15e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Pregabalin—epilepsy syndrome	6.02e-05	6.14e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Gabapentin—epilepsy syndrome	6e-05	6.12e-05	CcSEcCtD
Moxifloxacin—Headache—Pregabalin—epilepsy syndrome	5.99e-05	6.11e-05	CcSEcCtD
Moxifloxacin—Urticaria—Topiramate—epilepsy syndrome	5.86e-05	5.98e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Topiramate—epilepsy syndrome	5.83e-05	5.95e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Topiramate—epilepsy syndrome	5.83e-05	5.95e-05	CcSEcCtD
Moxifloxacin—Dizziness—Gabapentin—epilepsy syndrome	5.8e-05	5.91e-05	CcSEcCtD
Moxifloxacin—Nausea—Pregabalin—epilepsy syndrome	5.68e-05	5.79e-05	CcSEcCtD
Moxifloxacin—Vomiting—Gabapentin—epilepsy syndrome	5.57e-05	5.69e-05	CcSEcCtD
Moxifloxacin—Rash—Gabapentin—epilepsy syndrome	5.53e-05	5.64e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Gabapentin—epilepsy syndrome	5.52e-05	5.63e-05	CcSEcCtD
Moxifloxacin—Headache—Gabapentin—epilepsy syndrome	5.49e-05	5.6e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Topiramate—epilepsy syndrome	5.43e-05	5.54e-05	CcSEcCtD
Moxifloxacin—Asthenia—Topiramate—epilepsy syndrome	5.29e-05	5.4e-05	CcSEcCtD
Moxifloxacin—Pruritus—Topiramate—epilepsy syndrome	5.22e-05	5.32e-05	CcSEcCtD
Moxifloxacin—Nausea—Gabapentin—epilepsy syndrome	5.21e-05	5.31e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Topiramate—epilepsy syndrome	5.04e-05	5.15e-05	CcSEcCtD
Moxifloxacin—Dizziness—Topiramate—epilepsy syndrome	4.88e-05	4.98e-05	CcSEcCtD
Moxifloxacin—Vomiting—Topiramate—epilepsy syndrome	4.69e-05	4.78e-05	CcSEcCtD
Moxifloxacin—Rash—Topiramate—epilepsy syndrome	4.65e-05	4.74e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Topiramate—epilepsy syndrome	4.64e-05	4.74e-05	CcSEcCtD
Moxifloxacin—Headache—Topiramate—epilepsy syndrome	4.62e-05	4.71e-05	CcSEcCtD
Moxifloxacin—Nausea—Topiramate—epilepsy syndrome	4.38e-05	4.47e-05	CcSEcCtD
